A Phase Ia Clinical Study to Evaluate the Safety, Tolerability, PK and Immunogenicity of YBSW015 in Healthy Subjects
Clinical trial NCT05369754 · UNKNOWN
Trial details
- NCT number
- NCT05369754
- Sponsor
- Yabao Pharmaceutical Group
- Status
- UNKNOWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-01
- Primary completion
- 2023-01-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.